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Zinc plays a crucial role in growth and cell division, insulin activity, and in prostate health
(1,2). However, current dietary assessment tools do not adequately measure intake of zinc from
the diet and supplements (3–6). Biomarkers of exposure to trace elements are potentially useful
in epidemiologic studies, both as a measure of dietary intake and of nutritional status (7). The
most often used biomarker of zinc exposure in population studies is serum zinc concentrations,
but this method may be limited as a measure of zinc intake because plasma concentrations vary
day-to-day, have a diurnal variation and are influenced by concurrent infection (8–10).
Toenail clippings may serve as a useful method for assessing zinc status because they are more
convenient to collect and store than blood. Also, in contrast to serum, toenail clippings may
provide a more stable measure of zinc status. Garland et al. reported good long-term reliability
of toenail zinc measures, with a correlation of 0.58 across two toenail zinc samples taken 6
years apart (11).
Despite the fact that toenail zinc has potential for, and has been used as, a measure of zinc
exposure in epidemiologic studies of cardiovascular disease and cancer (12–14), there are no
prior studies to our knowledge that have examined how this marker varies with zinc intake
from food or supplements and only one prior study of how this marker varies with other factors
such as smoking, alcohol and body mass (13).
MATERIALS AND METHODS
Participants in this study were 106 men and 106 women, age 50–76 years, in Washington State
without insulin-dependent diabetes who were randomly selected to be in the measurement sub-
study (15) of the VITamins And Lifestyle (VITAL) cohort study. Of those randomly selected
participants, 73% completed the study protocol.
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Participants completed the VITAL baseline mailed, self-administered questionnaire in 2000–
01. Average daily supplemental zinc intake (current use for at least a year) was computed by
dividing reported days per week by seven and multiplying by dose per day. This number was
then summed for both individual zinc supplements and multivitamins. Dose of zinc in
multivitamins was based on the selected brand or by the participant specifying the full content
of their brand.
Diet over the previous year was assessed by a semi-quantitative food frequency questionnaire
(FFQ) developed at the Hutchinson Cancer Center (16), which covers 120 foods or food groups.
Nutrient intake was computed based on nutrient values from the Minnesota Nutrition Data
System (17). Participants were excluded from the nutrient calculations if they failed quality
control checks or had energy intake out of a plausible range (800 – 5000 kcal for men or 600
– 4000 kcal for women).
Participants were asked to clip their toenails from all 10 toes, which were collected during the
measurement study home visit that occurred approximately 3– 5 months after the FFQ data
was received. Toenail zinc concentrations in parts per million (ppm) were determined by
instrumental neuron activation analysis at the University of Missouri Research Reactor Center
(Columbia, Missouri) (11).
Linear regression was used to estimate associations of zinc intake from diet and supplements
and other covariates with toenail zinc. All analyses were adjusted for demographic factors (age,
gender and race as white/non-white) and the factors that were significant or borderline
significant predictors of toenail zinc in a model with the demographic factors (body mass index
(BMI), dietary zinc, vegetable intake, dietary fiber, and iron from diet).
RESULTS
Mean toenail zinc concentrations for men and women were 66.9 (s.d. 17.4 ppm) and 60.2 (s.d.
14.0 ppm), respectively.
Table 1 lists the crude and adjusted differences of toenail zinc concentrations by demographic
and nutrient variables. Even after adjustment, toenail zinc concentration in men waps 5.8 ppm
greater than in women (p = 0.04). BMI had borderline significant associations with toenail zinc
(p for trend = 0.11). For all other demographic factors (age and race) and health-related
behaviors (smoking and exercise (data not shown)), we did not find any statistically significant
differences.
Zinc supplement use was not a significant predictor of toenail zinc, whereas higher intake of
dietary zinc was associated with higher toenail zinc concentrations (p for trend = 0.03). The
dietary zinc-toenail zinc association was stronger for men and weak for women (p for
interaction = 0.05, data not shown). Animal protein, the major source of bioavailable zinc in
the diet, was not associated with toenail zinc.
We specifically examined other dietary factors that have been found to negatively influence
zinc absorption including phytic acid, vegetable and fiber intake (as surrogates of phytic acid),
iron and calcium from food supplements and alcohol intake (8,18–20) (some data not shown).
There was a borderline significant association between increased vegetable intake and
decreased toenail zinc (p for trend = 0.08). Conversely, dietary fiber intake was associated with
an increase in toenail zinc (p for trend = 0.04). We also investigated the potential effect
modification of the dietary zinc-toenail zinc association by vegetable, fiber and iron intake,
and there was no significant effect modification (data not shown).
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To our knowledge, we are the first to demonstrate an association between dietary intake of zinc
and toenail zinc concentrations. Observational studies of dietary zinc intake and plasma zinc,
another biomarker of zinc status, have reported no association in a US population (21), while
one in the UK found a positive association (22).
We found no association between supplemental zinc and toenail zinc, even though use of
supplemental zinc was high in our study (66%) and despite evidence that our questionnaire
accurately measures supplemental zinc (15). Reasons for our null association may be that zinc
found in supplements is in the inorganic form (bound to chloride, sulfate, oxides, or propionate)
which may not be well absorbed (23,24), and that zinc absorption from supplements may be
low when dietary intake is sufficient (25). However, results from randomized clinical trials
have shown that zinc supplementation positively affects zinc plasma levels (26–28).
A borderline statistically significant inverse association was seen for vegetable intake. Our
results are consistent with studies which suggest that zinc in vegetables has poor bioavailability,
and moreover, the phytate content of vegetables decreases the absorption of zinc from all
sources (8,18).
Dinsmore et al. demonstrated lower absorption of zinc in alcoholics (29). We found alcohol
intake was not associated with toenail zinc, nor was it in the study by Martin-Moreno et al.
(12). Our results are also consistent with the latter study in that both found a small, non-
significant increase in toenail zinc with increasing BMI and no association with smoking status.
In summary, our results suggest that toenail zinc may be a useful biomarker in epidemiologic
studies, because it varies with dietary zinc intake, even in a healthy population with presumably
little zinc deficiency.
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Table 1
Association of Demographic, Behavioral and Nutrient Factors with Toenail Zinc
Concentrations
Factor N1 Unadjusted Beta2 Adjusted Beta2
Sex
Female 106 Ref Ref
Male 106 6.70 5.82
p-value 0.04
Age (years)
50–55 50 Ref Ref
55–60 53 −1.98 0.40
60–65 36 1.84 3.97
65–70 29 −1.78 −0.23
70–77 44 −3.42 2.21
p-trend 0.56
Race
White 201 Ref Ref
Non-white 10 −6.34 −8.02
p-value 0.15
Body mass index (kg/m2)
Normal (18–24.9) 84 Ref Ref
Overweight (25–30) 86 6.11 4.82
Obese (>30) 36 6.80 4.24
p-trend 0.11
Zinc supplement use (mg/day) (individual plus multivitamins)
Non-User 72 Ref Ref
0–15 86 1.34 2.92
15.01–122.5 51 2.40 2.84
p-trend 0.30
Dietary zinc (mg/day)3
Q1 (0–8.76) 48 Ref Ref
Q2 (8.77–11.96) 51 1.70 2.63
Q3 (11.97–15.14) 49 3.82 5.83
Q4 (15.15–35.32) 51 5.34 10.98
p-trend 0.03
Diet plus zinc supplement use (mg/day)3
Q1 (0–14.69)
Q2 (14.70–24.03) 48 Ref Ref
Q3 (24.04–35.12) 49 3.75 3.93
Q4 (35.13–138.8) 49 2.60 0.51
p-trend 50 4.99 4.72
Animal protein (g/day)3
Q1 (0–34.7) 51 Ref Ref
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Factor N1 Unadjusted Beta2 Adjusted Beta2
Q2 (34.71–50.14) 51 2.04 −2.10
Q3 (50.15–65.47) 51 0.92 −2.93
Q4 (60.48–155.76) 51 4.02 −2.84
p-trend 0.48
Vegetable intake (servings/day)3
Q1 (0–1.22) 50 Ref Ref
Q2 (1.221–1.85) 50 6.10 5.13
Q3 (1.851–2.78) 49 −1.64 −2.60
Q4 (2.781–7.15) 49 −5.28 −6.51
p-trend 0.08
Dietary fiber (g/day)3
Q1 (0–12.89) 50 Ref Ref
Q2 (12.90–18.81) 48 −.25 2.19
Q3 (18.82–25.08) 50 2.15 9.97
Q4 (25.09–50.39) 51 −0.19 10.31
P-trend 0.04
Alcohol (g/day)3
Q1 (0–0.053) 52 Ref Ref
Q2 (0.531–2.35) 53 −2.43 −0.24
Q3 (2.35–11.25) 53 4.24 4.88
Q4 (11.26–102.36) 50 2.79 2.88
p-trend 0.19
Iron supplement (mg/day)
Non-users 104 Ref Ref
0–7.85 35 7.22 6.75
7.86–18 58 4.56 3.10
18.01–54 12 4.57 3.93
p-trend 0.17
Dietary iron (mg/day)3
Q1 (0–10.84) 49 Ref Ref
Q2 (10.85–14.40) 49 −2.18 −8.28
Q3 (14.41–18.94) 51 1.14 −4.47
Q4 (18.95–41.41) 50 0.73 −9.94
p-trend 0.26
1
Number of subjects = 212. Numbers do not total 212 due to missing data.
2
Beta coefficients represent the difference from the reference group in ppm of toenail zinc. Adjusted betas are adjusted for age, gender, race (white, non-
white), BMI, dietary iron, dietary zinc, vegetable intake, and dietary fiber. All adjustment variables are continuous except for gender and race.
3
Q1–Q4 = quartiles
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